Sware

📍 Chelsea, United States🗓 Founded 2015👥 74 employees💰 Last funded Sep 2023
Sware is a tech-first company, transforming compliance in life sciences and supporting an industry-wide transition from an inefficient, manual approach to an automated, workflow-driven, data-centric solution. Sware delivers process automation and a single source of validation truth for customers who want ground-breaking results. By driving the end-to-end validation process, Sware’s platform enables painless adoption of emerging technologies for healthcare, life sciences, and SaMD companies. With advanced technology and automation, Sware ensures consistency in compliance and keeps companies in a state of inspection readiness. We have helped more than 275 healthcare and life sciences companies transition to the regulated cloud. With advanced technology and automation, Sware was founded by the same leaders who took Veeva Vault and the life sciences industry into the cloud. Today, we’re evolving to meet the needs of Validation 4.0 by instilling trust and quality in the new technologies of Pharma 4.0. Validation to Sware by.
3
Total investors
0
Early stage
1
Mid stage
2
Late stage
2015
Founded
Investor geography1 country
United States
3
Investor activity2020–2023 · investors recorded per year
202012022120231
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Sware?
Sware has 3 investors on record on gritt.io, 1 mid-stage and 2 late-stage investors.
When did Sware last raise funding?
The most recent investment in Sware recorded on gritt.io was in September 2023.
When was Sware founded?
Sware was founded in 2015.
What industry is Sware in?
Sware operates in Software Development. Find similar Software Development investors on gritt.io.
Where is Sware based?
Sware is headquartered in Chelsea, United States.